filings.toolsItem 5. Other Information
6K characters. Original on sec.gov · Markdown
Item 5. Other Information
Rule 10b5-1 Trading Plans
In accordance with the disclosure requirement set forth in Item 408(a) of Regulation S-K, the following table discloses the officers (as defined in Rule 16a-1(f) under the Exchange Act) and directors who adopted a contract, instruction or written plan for the sale of the Company’s securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) during the quarter ended March 31, 2025. Each of these trading plans was adopted during an open trading window.
| Name / Title | Type of Plan | Adoption Date | End Date | Aggregate Number of Securities to be Sold | Plan Description | ||||||||||||
| Christopher Kempczinski / Chairman, President and Chief Executive Officer | Rule 10b5-1 trading plan | February 14, 2025 | May 10, 2026 | 52,553 | Exercise and sale of stock options | ||||||||||||
| Morgan Flatley / EVP – Global Chief Marketing Officer and New Business Ventures | Rule 10b5-1 trading plan | February 20, 2025 | June 21, 2026 | 13,042 | Exercise and sale of stock options, and sale of shares | ||||||||||||
| Ian Borden / EVP – Global Chief Financial Officer | Rule 10b5-1 trading plan | February 20, 2025 | February 11, 2026 | 17,134 | Exercise and sale of stock options | ||||||||||||
| Desiree Ralls-Morrison / EVP – Global Chief Legal Officer | Rule 10b5-1 trading plan | February 27, 2025 | December 31, 2025 | 4,973 | Sale of shares |
Other than as disclosed above, no officer or director adopted, modified, or terminated a contract, instruction or written plan for the purchase or sale of the Company’s securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or a non-Rule 10b5-1 trading arrangement.
| Item 6. Exhibits | |||||||||||||||||
| Exhibit No. | Description | ||||||||||||||||
| (31.1) | Rule 13a-14(a) Certification of Chief Executive Officer. | ||||||||||||||||
| (31.2) | Rule 13a-14(a) Certification of Chief Financial Officer. | ||||||||||||||||
| (32.1) | Certification pursuant to 18 U.S.C. Section 1350 by the Chief Executive Officer, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||||||||||||||||
| (32.2) | Certification pursuant to 18 U.S.C. Section 1350 by the Chief Financial Officer, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||||||||||||||||
| (101.INS) | XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | ||||||||||||||||
| (101.SCH) | Inline XBRL Taxonomy Extension Schema Document. | ||||||||||||||||
| (101.CAL) | Inline XBRL Taxonomy Extension Calculation Linkbase Document. | ||||||||||||||||
| (101.DEF) | Inline XBRL Taxonomy Extension Definition Linkbase Document. | ||||||||||||||||
| (101.LAB) | Inline XBRL Taxonomy Extension Label Linkbase Document. | ||||||||||||||||
| (101.PRE) | Inline XBRL Taxonomy Extension Presentation Linkbase Document. | ||||||||||||||||
| (104) | Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document. | ||||||||||||||||
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| McDONALD’S CORPORATION (Registrant) | ||||||||||||||
| /s/ Ian F. Borden | ||||||||||||||
| Date: | May 12, 2025 | Ian F. Borden | ||||||||||||
| Executive Vice President and Global Chief Financial Officer |
Previous: Item 1A. Risk Factors